Hemolytic Anemia Interpretation
Use
The Hemolytic Anemia Interpretation test is used to evaluate lifelong or inherited hemolytic anemias, including red cell membrane disorders, unstable or abnormal hemoglobin variants, and red cell enzyme disorders. It assesses for possible hereditary causes of increased red cell destruction and provides an interpretation based on specific clinical findings.
Special Instructions
This test requires a normal shipping control for osmotic fragility (OF) tests to exclude false-positive results due to preanalytical artifacts. OF and eosin-5-maleimide (EMA) binding tests will be canceled if no shipping control is received or if it is abnormal.
Limitations
The panel is not suitable for patients with likely immune-mediated hemolytic anemia such as that due to either warm or cold antibodies or to paroxysmal nocturnal hemoglobinurias. Recent transfusion can cause unreliable results. Acquired hemolytic anemias should be excluded before ordering this panel.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 59466-3
- 59466-3
- 18771-6
Result Turnaround Time
2-10 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Container
ACD-B
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 72 hours |